B. de Valk
AuthID: R-00G-MFD
1
TITLE: First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients
AUTHORS: Smith, IE; Y Pierga; Biganzoli, L; Cortes Funes, H; Thomssen, C; Pivot, X; Fabi, A; Xu, B; Stroyakovskiy, D; Franke, FA; Kaufman, B; Mainwaring, P; Pienkowski, T; De Valk, B; Kwong, A; Gonzalez Trujillo, JL; Koza, I; Petrakova, K; Pereira, D; Pritchard, KI;
PUBLISHED: 2011, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 22, ISSUE: 3
AUTHORS: Smith, IE; Y Pierga; Biganzoli, L; Cortes Funes, H; Thomssen, C; Pivot, X; Fabi, A; Xu, B; Stroyakovskiy, D; Franke, FA; Kaufman, B; Mainwaring, P; Pienkowski, T; De Valk, B; Kwong, A; Gonzalez Trujillo, JL; Koza, I; Petrakova, K; Pereira, D; Pritchard, KI;
PUBLISHED: 2011, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 22, ISSUE: 3
